Results 41 to 50 of about 57,515 (295)

Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants

open access: yesFrontiers in Immunology, 2019
Differences in Bacille Calmette-Guérin (BCG) immunogenicity and efficacy have been reported, but various strains of BCG are administered worldwide. Since BCG immunization may also provide protection against off-target antigens, we sought to identify the ...
Agano Kiravu   +17 more
doaj   +1 more source

Victims of Conspiracies? An Examination of the Relationship Between Conspiracy Beliefs and Dispositional Individual Victimhood

open access: yesEuropean Journal of Social Psychology, EarlyView.
ABSTRACT Conspiracy beliefs have been linked to perceptions of collective victimhood. We adopt an individual perspective on victimhood by investigating the relationship between conspiracy beliefs and the individual disposition to perceive and react to injustice as a victim, i.e., victim justice sensitivity (VJS). Data from two German samples (Ns = 370,
Daniel Toribio‐Flórez   +66 more
wiley   +1 more source

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model. [PDF]

open access: yes, 2014
BACKGROUND: Bacillus Calmette-Guerin (BCG) vaccine is the most widely administered vaccine in the world, yet its mechanism of action remains unclear. We hypothesize that certain immune pathways are associated with reduced mycobacterial growth following ...
Chomka, Agnieszka   +7 more
core   +1 more source

Adverse reactions due to the bacillus Calmette-Guerin vaccine: Twenty Tunisian cases

open access: yesIndian Journal of Dermatology, 2018
Background: Bacillus Calmette-Guérin (BCG) vaccine is a widely used vaccine. Management of local BCG complications differs between clinicians, and the optimal approach remains unclear.
Khadija Sellami   +10 more
doaj   +1 more source

The BCG Vaccine for COVID-19: First Verdict and Future Directions

open access: yesFrontiers in Immunology, 2021
Despite of the rapid development of the vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it will take several months to have enough doses and the proper infrastructure to vaccinate a good proportion of the world ...
Maria Gonzalez-Perez   +6 more
doaj   +1 more source

Is It an Intrapericardial Mass or a Localized Pericardial Effusion? A Case Report of Tuberculous Pericarditis Evaluated by Multimodal Imaging

open access: yesJournal of Clinical Ultrasound, EarlyView.
Tuberculous pericarditis is a common type of pericarditis, but it is difficult to be diagnosed. The application of combined transesophageal echocardiography, contrast echocardiography, and CT multimodal imaging provides sufficient clinical diagnosis basis and guidance for distinguishing encapsulated pericardial effusion or mass.
Yang Han   +5 more
wiley   +1 more source

Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses.

open access: yes, 2014
BCG protection varies and in some places (nearest the equator) is low or absent. Understanding this variation can inform the efforts to develop new vaccines against tuberculosis.
Abu-Raddad   +56 more
core   +1 more source

Bacterial outer membrane vesicles and vaccine applications [PDF]

open access: yes, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Acevedo, Reinaldo   +10 more
core   +2 more sources

Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection. [PDF]

open access: yes, 2020
Tuberculosis (TB) is the most lethal infection among infectious diseases. The specific aim of this study was to establish panels of serum protein biomarkers representative of active TB patients and their household contacts who were either infected (LTBI)
Anibarro, L   +11 more
core   +2 more sources

What Have We Learnt about BCG Vaccination in the Last 20 Years?

open access: yesFrontiers in Immunology, 2017
A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which include genetically modified mycobacteria, mycobacterial antigens delivered by viral vectors, or mycobacterial antigens in adjuvant. Some of these vaccines aim to
Hazel M. Dockrell, Steven G. Smith
doaj   +1 more source

Home - About - Disclaimer - Privacy